Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.
about
Lung cancer staging: clinical and radiologic perspectivesEvaluation of lymph node metastasis in lung cancer: who is the chief justice?A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.Diagnostic value of EBUS-TBNA for lung cancer with non-enlarged lymph nodes: a study in a tuberculosis-endemic country.Mediastinal staging of non-small-cell lung cancer.Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer.Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer stagingPositron emission tomography/computed tomography for bone tumors (Review).18F-FDG PET/CT imaging in oncologyThoroughness of mediastinal staging in stage IIIA non-small cell lung cancer.An analysis of the utility of handheld PET probes for the intraoperative localization of malignant tissue.Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.False positive and false negative FDG-PET scans in various thoracic diseases.Isolated mediastinal adenopathy: the case for mediastinoscopy18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.A Model Predicting Lymph Node Status for Patients with Clinical Stage T1aN0-2M0 Nonsmall Cell Lung Cancer.A pilot study of 4'-[methyl-11C]-thiothymidine PET/CT for detection of regional lymph node metastasis in non-small cell lung cancer.PET and PET-CT in radiation treatment planning for lung cancer.Diagnostic imaging in the preoperative management of lung cancer.PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT.New PET/CT criterion for nodal staging in non-small cell lung cancer: measurement of the ratio of section area of standard uptake values ≥2.5/lymph node section area.Staging lung cancer: role of endobronchial ultrasound.Tumor heterogeneity on (18)F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib.Improving radiation therapy for non-small cell lung cancer: molecular imaging and a team-based approach.Staging of non-small cell lung cancer (NSCLC).Advances in radiological staging of non-small cell lung cancer (NSCLC).[A study on the application of 18F-FDG-PET-CT for the radiotherapy of patients with stage III non-small cell lung cancer].The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer.Roles of EBUS-TBNA in non-small cell lung cancer.Metallic copper as a fiducial marker for both CT and PET.Dose escalation of radical radiation therapy in non-small-cell lung cancer using positron emission tomography/computed tomography-defined target volumes: are class solutions obsolete?Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer?Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer.Identifying patients with peripheral-type early non-small cell lung cancer (T1N0M0) for whom irradiation of the primary focus alone could lead to successful treatment.Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: a prospective study.Sounding the mediastinum.
P2860
Q24600394-31BBC141-C852-467E-9AE3-F716BEAD2703Q26774986-3F23F1F8-0A10-43D9-B30E-3F358CA320C8Q30845191-2BEB7002-B15F-4A49-ACAD-4797FF16403AQ33833869-4C5EB80E-0282-4497-8CCB-6D3B5EA7E581Q34325208-D632AAE3-D6A4-4F81-909C-44E9B9BD7C13Q34390410-2B5D0B71-8E75-4E3A-A00E-9A93830DF787Q34683147-1F6CBC9F-D93A-4888-A73D-D4FC9A84E1D7Q34993781-6A46877A-8F0F-47EA-B2C6-66200983FE34Q35006097-1F8C5424-5840-4F8B-9082-87B9D500873DQ35659621-556F22C9-6D58-4236-90AC-BF688B7E2429Q35744447-2E240983-D4A2-4FC6-9010-1A62EF87299EQ35941636-7D0C99A1-4FFD-4106-A3B9-9BD775624F66Q36426674-C8743463-A18B-412D-BC14-B4CDA0F262E3Q36837891-D755435E-12D2-4A9D-9C49-75EC4ECCDBBCQ37016566-CE70E09E-BA58-49DA-B2B6-A182D2C40BA8Q37058676-E6071042-37BC-40F9-BF62-AAA48C875EAAQ37663524-1FC10C47-91C5-4312-9D85-95F5B029FA82Q37686084-28AB696C-D013-4FE3-BD56-FDB2E1AFE01BQ37732292-CE4DEE21-4386-443A-9897-58C846DC2314Q38120418-E3EC8985-9CA8-44FE-8331-B33A5F11CF68Q38135254-A3B4E61F-1005-42EF-B115-60C1BD1693E6Q38255000-BB8BB3CD-DBE0-4622-9BC9-4F92A0966306Q38947114-257C130C-9C14-4C30-90A2-50850EC09A2FQ39139900-1D079916-70ED-44C8-864B-21FB182B4896Q39433202-0D7ECC84-BBE8-4091-8473-D61F05E529B4Q40255849-76B3ABC0-92AD-4370-AEB0-E783EF89FF50Q40895862-E90E33D6-74C4-49BB-927D-6E3BF565ACA1Q41973755-69998D98-CAAD-4D17-8CFA-5FF44BD9AB6DQ42951210-0108C7CE-165B-4DD5-B512-1866599C3816Q44407184-4437B1BC-D2CD-43DC-9E82-F8AF7FBCFCF7Q46503582-42DA7832-B0A6-4C9B-9692-86F884BE6CF9Q50050221-7FCAC78B-4EA1-4B73-BBA0-D640E6986185Q51598313-0988F579-0BD5-4B13-B51E-75372B5C727CQ53036226-EC5EFE18-1B83-47EB-A70C-638B32F59973Q53051630-9D616B97-B182-468E-B529-534B6EFB973FQ53376866-7F09322E-166D-4007-BF0E-72A34C06144BQ53404049-CAD2CF3D-63D3-4044-B110-70BB96C2C231Q53511553-02FB6DE2-4B8E-4B95-9420-39AFAC39DB9FQ53591249-E2D3929E-9C8A-45D1-9E9E-21939D0BB531Q53637198-86D146F3-6153-4EA4-892F-14EDB9A94FE6
P2860
Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Comparative efficacy of positr ...... ge (>3 cm) lymph node lesions.
@en
Comparative efficacy of positr ...... ge (>3 cm) lymph node lesions.
@nl
type
label
Comparative efficacy of positr ...... ge (>3 cm) lymph node lesions.
@en
Comparative efficacy of positr ...... ge (>3 cm) lymph node lesions.
@nl
prefLabel
Comparative efficacy of positr ...... ge (>3 cm) lymph node lesions.
@en
Comparative efficacy of positr ...... ge (>3 cm) lymph node lesions.
@nl
P2093
P356
P1433
P1476
Comparative efficacy of positr ...... ge (>3 cm) lymph node lesions.
@en
P2093
P304
P356
10.1378/CHEST.117.3.773
P407
P577
2000-03-01T00:00:00Z